Headquarters Melbourne VIC, Australia
Stage Series A
Company Size 11-50 Employees

We are an Australian MedTech company with a vision to create a world with zero preventable deaths due to the lack of timely molecular-level data.

We are developing a Continuous Molecular Monitoring platform technology that can provide clinicians with real-time and continuous data for multiple targets.

To date, we have raised $10 million, won an award for Technology Platform Solution of the Year at the National iawards, and been a Top 5 finalist in the medTech Innovator program. Our team of 15 are currently working towards our first-in-human clinical trials.